CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study 期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 期号: 1
作者:  Liu, Lunfei;  Chen, Jisu;  Xu, Jinhua;  Yang, Qinping;  Gu, Chaoying
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/04
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial 期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2019, 卷号: 173, 期号: 2
作者:  Lei, Li;  Li, Jian-wei;  Zuo, Wen-jia;  Ivanova, Diana;  Jia, Xiao-qing
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/04
Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Chang, Lung-Ji;  Li, Yuhua;  Tu, Sanfang;  Lai, Xun;  Huang, Rui
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/04
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial 期刊论文
AGE AND AGEING, 2017, 卷号: 46, 期号: 5
作者:  Xiao, Shifu;  Wang, Tao;  Ma, Xiuqiang;  Qin, Yingyi;  Li, Xia
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/04
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer"s disease: A phase II multicenter randomized controlled trial 期刊论文
Alzheimer"s and Dementia, 2015, 卷号: 11
作者:  Xiao S., Wang T., Li X., Zhao Z., Liu X., Wang X., Xie H., Sun L., Jiang Q., Luo B., Shang L., Chen W., Bai Y., Tang M., He M., Liu K., Ma Q., Song Z., Qin Y., Ma X., He J.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/04
Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 3
作者:  Lin, Feng
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04
A Phase II Study of MESA Chemotherapy for Newly Diagnosed, Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of Northern-West of China 期刊论文
BLOOD, 2015, 卷号: 126, 期号: 23
作者:  Liang, Rong;  Gao Guangxun;  Ping, Chen Jie;  Wang, Jishi;  Wang, Xiao Min
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/04
Phase II clinical trial of metronomic oral capecitabine therapy combined with aromatase inhibitors in postmenopausal metastatic and recurrent breast cancer resistant to first-line aromatase inhibitors 期刊论文
EUROPEAN JOURNAL OF CANCER, 2015, 卷号: 51
作者:  Jian-wei, L.;  Xiao-qing, J.;  Li, L.;  Yu-jie, W.;  Zhi-min, S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04
A Phase II study of MESA chemotherapy for newly diagnosed, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: A multicenter trial of Northern-West of China 期刊论文
Blood, 2015, 卷号: 126, 期号: 23
作者:  Liang R., Guangxun G., Ping C.J., Wang J., Wang X.M., Zeng Y., Chen X.Q., Zhang L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Efficacy and safety of capecitabine plus oxaliplatin (XELOX) as the perioperative treatment of patients with potentially resectable liver-only metastases from colorectal cancer: A single arm, open-label, multicenter phase II trial (ML22298; NCT00997685) 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Lin F., Li G., Chu Z., Hao C., Chen M., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/04

©版权所有 ©2017 CSpace - Powered by CSpace